510(k) device
eQUANT System
Avails Medical, Inc. · Positive Blood Culture Processor For Inoculum Preparation Used For Antimicrobial Susceptibility Testing (QZX, Class II) · First FDA decision Feb 8, 2024, newest Feb 8, 2024Sepsis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
0
Naming "eQUANT"
MAUDE reports
0
Brand "eQUANT", since 2015
PubMed studies
28
Mentioning "eQUANT"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing eQUANT System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- eQUANT System510(k)
K231536 · Decided Feb 8, 2024 · 254 days after receipt
Device type: Positive Blood Culture Processor For Inoculum Preparation Used For Antimicrobial Susceptibility Testing (QZX) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Blood Glucose TestingNational determinationOn the books190.20Updated Oct 1, 2026
- Lipid and Blood Glucose Testing (Modification of Code List to Implement Screening Benefit Added by Medicare Modernization Act (MMA)Coding analysisReview closedCAG-00266NUpdated Sep 14, 2026
- Blood Glucose Testing (Revision of ICD-9-CM Codes for Osteomyelitis)Coding analysisReview closedCAG-00183NUpdated Sep 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "eQUANT", any status and sponsor, newest update first.
No registered device study names "eQUANT".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "eQUANT", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QZX
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "eQUANT"[tiab]. The summary above synthesizes these.
- Novel electronic biosensor for automated inoculum preparation to accelerate antimicrobial susceptibility testing.
Putney S, Theiss AH, Rajan NK, et al. · Sci Rep · 2021
- Multicenter evaluation of the eQUANT system for use with disk diffusion AST of gram-negative bacteria directly from positive blood cultures.
Dutta S, Jacobs MR, Good CE, et al. · J Clin Microbiol · 2025Multicenter Study, Evaluation Study
- Pilot study evaluation of the eQUANTࡊ system for accelerated antimicrobial susceptibility testing of gram-negative organisms directly from positive blood cultures.
Abdelhamed AM, Alkins BR, Deak E, et al. · Diagn Microbiol Infect Dis · 2025Multicenter Study, Evaluation Study
- The relevance of rock shape over mass-implications for rockfall hazard assessments.
Caviezel A, Ringenbach A, Demmel SE, et al. · Nat Commun · 2021
- Key Signatures of Magnetofossils Elucidated by Mutant Magnetotactic Bacteria and Micromagnetic Calculations.
Amor M, Wan J, Egli R, et al. · J Geophys Res Solid Earth · 2022
- Crystal nucleation and growth of spherulites demonstrated by coral skeletons and phase-field simulations.
Sun CY, Gránásy L, Stifler CA, et al. · Acta Biomater · 2021Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- Long-term effects of wildfire on rock weathering and soil stoniness in the Mediterranean landscapes.
Shtober-Zisu N, Wittenberg L · Sci Total Environ · 2021
- Breakage Assessment of Lath-Like Crystals in a Novel Laboratory-Scale Agitated Filter Bed Dryer.
Goh WP, Sinha K, Nere NK, et al. · Pharm Res · 2022
- Continuum percolation for randomly oriented soft-core prisms.
Saar MO, Manga M · Phys Rev E Stat Nonlin Soft Matter Phys · 2002
- Detecting Blending End-Point Using Mean Squares Successive Difference Test and Near-Infrared Spectroscopy.
Khorasani M, Amigo JM, Bertelsen P, et al. · J Pharm Sci · 2015Comparative Study, Research Support, Non-U.S. Gov't
- Role of Molecular, Crystal, and Surface Chemistry in Directing the Crystallization of Entacapone Polymorphs on the Au(111) Template Surface.
Ma CY, Geatches D, Hsiao YW, et al. · Cryst Growth Des · 2023
- Slow-growing reef corals as climate archives: A case study of the Middle Eocene Climatic Optimum 40 Ma ago.
Brachert TC, Felis T, Gagnaison C, et al. · Sci Adv · 2022
Other devices of this type
Also filed under product code QZX.
- PBC Separator with Selux AST SystemSelux Diagnostics, Inc. · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.